首页> 外国专利> A method for the production of recombinant human gamma - interferon without without the methionine, cysteine, and at the n - terminal.

A method for the production of recombinant human gamma - interferon without without the methionine, cysteine, and at the n - terminal.

机译:一种生产重组人γ-干扰素的方法,该干扰素在无甲硫氨酸,半胱氨酸的情况下,在n-末端没有。

摘要

The method is used for the preparation of the -interferon medicament. It ensure product yield exceeding 1.109 U/l culture, and furthermore no momoclonal antibodies are used for its treatment. The -interferon, the N-end methionone of which is intercellularly removed has purity over 99.6%, preserves its biological activity after freeze-drying and is soluble in water solutions. The method is effected when plasmide pJMB-carrier of synthetic gene of recombinant human non-cystein -interferon is expressed in strain Escherichia coli LE 392, registered in NBIMCC under No. 845, and is cultivated in a fermenter at 36-38°C under conditions of aeration. The turned out product is purified, renaturated and eluated, and the accompanying solvents and impurities are removed.
机译:该方法用于制备干扰素药物。它确保产品产量超过1.109 U / l培养物,而且不使用单克隆抗体进行处理。干扰素(其N端甲硫酮在细胞内被去除)的纯度超过99.6%,冷冻干燥后保留其生物学活性,并溶于水溶液。当重组人非半胱氨酸-干扰素的合成基因的质粒pJMB载体在大肠杆菌LE 392菌株中表达,在NBIMCC中以845号注册,并在发酵罐中于36-38°C,曝气条件。将所得产物纯化,复性和洗脱,并除去伴随的溶剂和杂质。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号